PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

'Hi-JAK-ing' cancer by inhibiting Jak2

2010-09-13
(Press-News.org) Myeloproliferative neoplasms (MPN) comprise a family of blood cancers characterized by clonal expansion of a single blood cell type. Untreated, these cancers can progress to bone marrow failure and acute myeloid leukemia. Several groups have identified activating mutations in the JAK2 gene as associated with MPN; JAK2 inhibition has therefore emerged as approach to MPN therapy. Thus far, however, JAK2 inhibition strategies have had limited efficacy and have been accompanied by significant toxicity. In this paper, Ross Levine and his group at the Memorial Sloane Kettering Cancer Center, New York, describe an indirect approach to reducing JAK2 activity by pharmacologically targeting HSP90, a protein that stabilizes JAK2. Inhibiting HSP90 normalized blood counts and improved survival in two mouse models of MPN, and the treatment promoted JAK2 degradation in samples from MPN patients. The authors believe that targeting HSP90, perhaps in combination with JAK2 inhibition, may be the way forward in the treatment of patients with MPN.

INFORMATION:

TITLE:

HSP90 is a therapeutic target in JAK2-dependent myeloproliferative neoplasms in mice and humans

AUTHOR CONTACT:
Ross L. Levine,
Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Phone: 646.888.2796; Fax: 646.422.0890; E-mail: leviner@mskcc.org.

Gabriela Chiosis,
Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Phone: 646.888.2238; Fax: 646.422.0416; E-mail: chiosisg@mskcc.org.

James E. Bradner,
Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Phone: 617.632.6629; Fax: 617.582.7370; E-mail: james_Bradner@dfci.harvard.edu.

Media contact
Kathleen Harrison
Memorial Sloane Kettering Cancer Center, New York, New York.
Phone: 212.639.3573; E-mail: harrisok@mskcc.org.

View this article at: http://www.jci.org/articles/view/42442?key=7ef55d4a4ce9ffed3af0

END



ELSE PRESS RELEASES FROM THIS DATE:

JCI online early table of contents: Sept. 13, 2010

2010-09-13
EDITOR'S PICK Hi-JAK-ing Cancer by Inhibiting Jak2 Myeloproliferative neoplasms (MPN) comprise a family of blood cancers characterized by clonal expansion of a single blood cell type. Untreated, these cancers can progress to bone marrow failure and acute myeloid leukemia. Several groups have identified activating mutations in the JAK2 gene as associated with MPN; JAK2 inhibition has therefore emerged as approach to MPN therapy. Thus far, however, JAK2 inhibition strategies have had limited efficacy and have been accompanied by significant toxicity. In this paper, Ross ...

Exosomal release of beta-catenin may explain why CD82 and CD9 suppress tumor metastasis

Exosomal release of beta-catenin may explain why CD82 and CD9 suppress tumor metastasis
2010-09-13
Researchers reveal a new way in which cells restrain beta-catenin and potentially suppress tumor metastasis: the protein can be ejected from cells in small vesicles called exosomes. The study appears online on September 13 in the Journal of Cell Biology (www.jcb.org). Beta-catenin is a central component of the Wnt signaling pathway that controls cell proliferation and differentiation. Activation of the Wnt pathway stabilizes beta-catenin, allowing it to move into the cell nucleus and control the expression of many different genes. Michael Caplan's group at Yale University ...

Enlarged hearts in women shrink faster than those in men after aortic valve replacement

2010-09-13
Heart enlargement caused by narrowed aortic valves regresses faster in elderly women than in men after aortic valve replacement, according to research reported in a surgical supplement of Circulation: Journal of the American Heart Association. Men's slower heart-size regression times may be attributable to genetic differences that cause the heart to develop more fibrous tissue after surgery because of narrowed heart valves, a condition known as aortic stenosis. "We show for the first time that elderly women and men differ in their gene expression related to fibrous ...

New metabolic markers may predict preeclampsia in early pregnancy

2010-09-13
An international team of scientists and physicians used a combination of sophisticated emerging technologies and data analysis to detect 14 simple metabolites with high accuracy to predict in early pregnancy which women are at risk of developing preeclampsia in later pregnancy, according to a study reported in Hypertension: Journal of the American Heart Association. Currently there is no predictive test for the condition and no cure other than delivery of the baby. Preeclampsia is a life-threatening condition characterized by high blood pressure and high levels of protein ...

Available physician characteristics may not help patients find high-quality care

2010-09-13
Publicly available information about board certification, education and malpractice claims appear to provide consumers with little information about the quality of care individual physicians provide, according to a report in the September 13 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. "To improve the quality of care received by their beneficiaries, some health plans use physician report cards and tiered physician networks to steer their members toward physicians who provide high-quality care. However, most patients do not have access to ...

Diet/exercise intervention for patients at risk for heart disease improves quality of life

2010-09-13
A lifestyle intervention incorporating exercise training and diet counseling in primary health care settings appears to improve quality of life among adults at moderate to high risk for heart disease and appears cost-effective compared to standard care, according to a report in the September 13 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. Most individuals in developed countries do not reach recommended levels of physical activity, and are thus at higher risk of illness and death, according to background information in the article. "Extensive ...

Protein-based biomarkers in blood serum could classify individuals with Alzheimer's disease

2010-09-13
An initial analysis suggests that biomarkers in blood serum can be combined with clinical information to accurately classify patients with Alzheimer's disease, according to a report in the September issue of Archives of Neurology, one of the JAMA/Archives journals. "There is clearly a need for reliable and valid diagnostic and prognostic biomarkers of Alzheimer's disease, and in recent years, there has been an explosive increase of effort aimed at identifying such markers," the authors write as background information in the article. "It has been previously argued that, ...

Asthma medication may benefit patients with multiple sclerosis

2010-09-13
Adding albuterol, a compound commonly used to treat asthma and other respiratory diseases, to an existing treatment for patients with multiple sclerosis appears to improve clinical outcomes, according to a report in the September issue of Archives of Neurology, one of the JAMA/Archives journals. Multiple sclerosis (MS) is a chronic inflammatory disease characterized by the degeneration of myelin, which coats nerve cells in the white matter of the central nervous system. Patients with the condition have been found to have elevated levels of interleukin-12, a biological ...

Pilot study demonstrates safety of diabetes medication for patients with Alzheimer's disease

2010-09-13
A pilot study suggests the diabetes medication pioglitazone is generally well tolerated and may warrant further study as a treatment for patients with Alzheimer's disease, according to a report posted online today that will appear in the January 2011 print issue of Archives of Neurology, one of the JAMA/Archives journals. "Alzheimer's disease is an immense and growing public health problem," the authors write as background information in the article. "Although prescription drug therapy for the symptoms of Alzheimer's disease has been available since 1993, these agents ...

Antiviral therapy associated with fewer recurring eye problems from herpes simplex virus

2010-09-13
Taking oral antiviral medications following infection with the herpes simplex virus may be associated with a reduced risk of recurring eye-related manifestations of the disease, according to a report in the September issue of Archives of Ophthalmology, one of the JAMA/Archives journals. "Herpes simplex virus (HSV) is a common cause of corneal disease and is the leading infectious cause of corneal blindness among developed nations," the authors write as background information in the article. After the initial exposure to the virus and the resulting systemic infection, ...

LAST 30 PRESS RELEASES:

Reality check: making indoor smartphone-based augmented reality work

Overthinking what you said? It’s your ‘lizard brain’ talking to newer, advanced parts of your brain

Black men — including transit workers — are targets for aggression on public transportation, study shows

Troubling spike in severe pregnancy-related complications for all ages in Illinois

Alcohol use identified by UTHealth Houston researchers as most common predictor of escalated cannabis vaping among youths in Texas

Need a landing pad for helicopter parenting? Frame tasks as learning

New MUSC Hollings Cancer Center research shows how Golgi stress affects T-cells' tumor-fighting ability

#16to365: New resources for year-round activism to end gender-based violence and strengthen bodily autonomy for all

Earliest fish-trapping facility in Central America discovered in Maya lowlands

São Paulo to host School on Disordered Systems

New insights into sleep uncover key mechanisms related to cognitive function

USC announces strategic collaboration with Autobahn Labs to accelerate drug discovery

Detroit health professionals urge the community to act and address the dangers of antimicrobial resistance

3D-printing advance mitigates three defects simultaneously for failure-free metal parts 

Ancient hot water on Mars points to habitable past: Curtin study

In Patagonia, more snow could protect glaciers from melt — but only if we curb greenhouse gas emissions soon

Simplicity is key to understanding and achieving goals

Caste differentiation in ants

Nutrition that aligns with guidelines during pregnancy may be associated with better infant growth outcomes, NIH study finds

New technology points to unexpected uses for snoRNA

Racial and ethnic variation in survival in early-onset colorectal cancer

Disparities by race and urbanicity in online health care facility reviews

Exploring factors affecting workers' acquisition of exercise habits using machine learning approaches

Nano-patterned copper oxide sensor for ultra-low hydrogen detection

Maintaining bridge safer; Digital sensing-based monitoring system

A novel approach for the composition design of high-entropy fluorite oxides with low thermal conductivity

A groundbreaking new approach to treating chronic abdominal pain

ECOG-ACRIN appoints seven researchers to scientific committee leadership positions

New model of neuronal circuit provides insight on eye movement

Cooking up a breakthrough: Penn engineers refine lipid nanoparticles for better mRNA therapies

[Press-News.org] 'Hi-JAK-ing' cancer by inhibiting Jak2